Literature DB >> 21484253

The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

R A A Pondé1.   

Abstract

The course of HBV infection is determined by the interplay between viral replication via HBV protein production and the host's immune response. Therefore, the diagnosis of infection in clinical practice is established by the serological detection of HBV protein products as well as antibodies produced by the host. Although the serological findings for assessing the clinical course of infection are already well established, the expression of viral proteins and the dynamics of antibody production may vary during the natural course of infection. This causes the HBV infection to be occasionally associated with the presence of unusual serologic profiles, which can lead to doubts in the interpretation of results and mistaken serological diagnosis. The simultaneous detection of HBsAg and anti-HBs in the blood stream comprises an atypical serological profile, somewhat incoherent, whose significance can be complicated to establish. Outlined in this article are some immunological and molecular mechanisms which could justify the existence of this profile in which there is a great laboratorial and clinical interest.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484253     DOI: 10.1007/s10096-011-1240-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  101 in total

Review 1.  Naturally occurring variants of hepatitis B virus.

Authors:  S Günther; L Fischer; I Pult; M Sterneck; H Will
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

2.  Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable.

Authors:  R A Heijtink; P M Schneeberger; B Postma; W Crombach
Journal:  Vaccine       Date:  2002-07-26       Impact factor: 3.641

3.  Fatal HBV reactivation in a subject with anti-HBs and anti-HBc.

Authors:  Takeji Umemura; Kendo Kiyosawa
Journal:  Intern Med       Date:  2006-07-18       Impact factor: 1.271

4.  Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab.

Authors:  Toshiki Sera; Yoichi Hiasa; Kojiro Michitaka; Ichiro Konishi; Kana Matsuura; Yoshio Tokumoto; Bunzo Matsuura; Takeshi Kajiwara; Toshikazu Masumoto; Norio Horiike; Morikazu Onji
Journal:  Intern Med       Date:  2006-07-03       Impact factor: 1.271

5.  Glycoproteins of natural origin with an affinity for hepatitis B surface antigen.

Authors:  I Millman; J C McMichael
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

6.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

7.  Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.

Authors:  H Kohno; T Inoue; F Tsuda; H Okamoto; Y Akahane
Journal:  J Gen Virol       Date:  1996-08       Impact factor: 3.891

Review 8.  Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective.

Authors:  Li-Ming Wu; Xiao Xu; Shu-Sen Zheng
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-11

9.  A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J.

Authors:  Kanako Tatematsu; Yasuhito Tanaka; Fuat Kurbanov; Fuminaka Sugauchi; Shuhei Mano; Tatsuji Maeshiro; Tomokuni Nakayoshi; Moriaki Wakuta; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

10.  Discrimination of Antibodies to Hepatitis B surface antigen from antibodies to inherited serum protein variants in immune sera of human and animal origin.

Authors:  M H Solaas
Journal:  J Immunogenet       Date:  1979-10
View more
  14 in total

1.  Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

Authors:  Andrea Costantini; Katia Marinelli; Giulia Biagioni; Alessia Monachetti; Monica L Ferreri; Luca Butini; Maria Montroni; Aldo Manzin; Patrizia Bagnarelli
Journal:  BMC Infect Dis       Date:  2011-11-04       Impact factor: 3.090

Review 2.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

3.  Prevalence of Hepatitis B Virus Infection Markers among Patients of the Ibn Sina University Hospital Center (Rabat, Morocco).

Authors:  Mourad Feindiri; Hakima Kabbaj; Mohammed El Mzibri; Bouchra Belkadi; Najat Bouihat; Abdelkarim Filali-Maltouf; Myriam Seffar
Journal:  Intervirology       Date:  2021-09-10       Impact factor: 2.294

4.  Identified OAS3 gene variants associated with coexistence of HBsAg and anti-HBs in chronic HBV infection.

Authors:  S Wang; J Wang; M-J Fan; T-Y Li; H Pan; X Wang; H-K Liu; Q-F Lin; J-G Zhang; L-P Guan; D V Zhernakova; S J O'Brien; Z-R Feng; L Chang; E-H Dai; J-H Lu; H-L Xi; Z Zeng; Y-Y Yu; B-B Wang
Journal:  J Viral Hepat       Date:  2018-05-29       Impact factor: 3.728

Review 5.  Atypical serological profiles in hepatitis B virus infection.

Authors:  Robério A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-29       Impact factor: 3.267

6.  Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.

Authors:  Yong Liu; Le Zhang; Jin-Yong Zhou; Jinshun Pan; Wei Hu; Yi-Hua Zhou
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

7.  Evolution of full-length genomes of HBV quasispecies in sera of patients with a coexistence of HBsAg and anti-HBs antibodies.

Authors:  Tai-Cheng Zhou; Xiao Li; Long Li; Xiao-Fei Li; Liang Zhang; Jia Wei
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

8.  Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B.

Authors:  Min-Sun Kwak; Goh-Eun Chung; Jong In Yang; Jeong Yoon Yim
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

9.  Patients with Coexistence of Circulating Hepatitis B Surface Antigen and Its Antibody May Have a Strong Predisposition to Virus Reactivation During Immunosuppressive Therapy: A Hypothesis.

Authors:  Yu-Lan Chen; Ying-Qian Mo; Dong-Hui Zheng; Jian-Da Ma; Jun Jing; Lie Dai
Journal:  Med Sci Monit       Date:  2017-12-17

10.  Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs.

Authors:  Yan Qiao; Shanshan Lu; Zhihui Xu; Xiaodong Li; Kai Zhang; Yan Liu; Li Zhao; Rongjuan Chen; Lanlan Si; Shumei Lin; Dongping Xu; Jin Li
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.